薛宜家 林志堅 / Taipei Report ; Published：2021-09-23 12:56 Updated : 2021-09-23 14:43

2021/9/23 12:51 (Updated 9/23 13:21)

A team from Academia Sinica's Agricultural Biotechnology Center has discovered a gene that, if overexpressed, leads to the failure of pancreatic beta-cells. Consequently, late-stage diabetic patients must rely solely on insulin injections to slow the progression of the disease. However, now that the mechanism of this gene is understood, they have...

The current situation where diabetes is considered incurable is set to be reversed! A team led by Dr. Wen-Ching Yang, a research fellow at the Agricultural Biotechnology Research Center of Academia Sinica, discovered through mouse experiments that Pdia4 (Protein Disulfide Isomerase) is responsible for regulating pancreatic beta-cells. By using the...

Dr. Wen-Ching Yang's research team at Academia Sinica discovered that Pdia4 is mainly expressed in pancreatic beta-cells, and over-nutrition increases the expression of Pdia4 in human and mouse beta-cells. In diabetic mice, the Pdia4 gene knockout was found to alleviate diabetes and islet failure in the disease model, simultaneously lowering...

Diabetes Future Research and Application Symposium

In April 2021, Pharmasaga presented the latest research results of PS-001 at the Demo Day event hosted by Academia Sinica's Center for Translational Research. The presentation received an enthusiastic response from many investors and professionals in attendance.

The Future Tech Exhibition 2020 (FUTEX 2020) was held from September 24th to September 26th, 2020, with over 600 startup teams participating. Our first-in-class diabetes drug, PS1, was highly honored receiving the prestigious Future Tech Award, and earning recognition from numerous domestic experts. We firmly believe that in the near future, PS1...